SOPH Stock Analysis: Buy, Sell, or Hold?
SOPH - SOPHiA GENETICS SA Ordinary Shares
$5.35
-0.24 (-4.29%)
▼
5d:
-5.98%
30d:
+8.3%
90d:
+5.11%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When SOPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SOPH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SOPH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SOPH is currently trading at $5.35, which is considered extended relative to its 30-day fair value range of $4.89 to $5.57.
Technical Outlook: Technically, SOPH is in a uptrend. Immediate support is located at $5.08, while resistance sits at $6.30. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: SOPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+49.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SOPH is in a uptrend. Immediate support is located at $5.08, while resistance sits at $6.30. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: SOPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+49.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.89 -
$5.57
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 49.5% below Wall St target ($8.00)
- CAUTION: 5-day price weakness (-6.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.89 -
$5.57
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.08
Resistance Level
$6.30
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.55
Wall Street Target
$8.00
(+49.5%)
Revenue Growth (YoY)
22.0%
Profit Margin
-99.7%
Share & Embed Analysis
Last updated: July 02, 2026 9:42 PM ET
Data refreshes hourly during market hours. Next update: 10:42 PM
Data refreshes hourly during market hours. Next update: 10:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Puylaert
SELL
33 shares
2026-04-20
Manuela Valente
SELL
380 shares
2026-04-20
Philippe Menu
SELL
608 shares
2026-04-20
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |
